Pharmacogenomic Resources  

Course card Final.png

Join our online course

Want to learn how to use these resources to improve drug response in your patients?

Learn the basics of how to implement pharmacogenomic testing in your practice with Dr. Jeanette McCarthy, a genome scientist and leading educator in the field of precision medicine.

 

PGx Professional Guidelines

cpic-200.png

Evidence-based guidelines providing dosing recommendations based on pharmacogenetic test results.

PGx Knowledge-base

PharmGKB.png

A searchable pharmacogenomics knowledge base with clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships.

Medical Genetic Summaries

 
med genetic summaries.png

These clinically-focused, succinct summaries include dosing recommendations from FDA label and professional guideline for 42 pharmacogenetic tests

 

Insurance coverage policies for pharmacogenomics

 
Anthem Coverage Policy

Anthem Coverage Policy

Aetna Coverage Policy

Aetna Coverage Policy

Humana Coverage Policy

Humana Coverage Policy

UHC Coverage Policy

UHC Coverage Policy

Cigna Coverage Policy

Cigna Coverage Policy

 

Comprehensive PGx panel testing 

Several companies offer pharmacogenomic tests that cover a broad range of prescription drugs. These tests are affordable and increasingly being used as a screening test in healthy individuals who wish to have their pharmacogenomic information available in their medical record preemptively.

Below are some examples of broad pharmacogenomic panel tests covering a large number of drugs currently on the market. Learn how to interpret a test report or how to talk to your patients about Pharmacogenomics and walk away with the confidence to begin offering genetic testing for drug response to your patients.

White paper: A comparison of comprehensive pharmacogenomic tests

Whiteppaer.png

Several factors go into selecting a PGx gene panel test including which genes are on the panel, the scope of variants detected, as well as cost, insurance reimbursement, turn-around-time, ease of use of the report, integration of results into the EHR and other factors.

In this white paper, we dig into commercially available comprehensive PGx tests and compare and evaluate the clinical validity of the genes analyzed. 

View sample pharmacogenomic test reports

 
Admera Test Report

Admera Test Report

Kailos Test Report

Kailos Test Report

Phosphorus Test Report

Phosphorus Test Report

GeneDX Test Report

GeneDX Test Report

OneOme Test Report

OneOme Test Report

 

With so many laboratories and tests available, the decision about which one to use can be overwhelming.

If you want to learn to implementing pharmacogenomic testing in the clinic, join us as we break down the key factors on which to judge a pharmacogenomic test, review sample test reports from major labs and learn how to navigate the results.

Our blog post: 23andMe is offering pharmacogenomic testing, but is it any good?

23andm3.png

23andMe has recently received FDA clearance to offer pharmacogenetic testing to its customers. The test covers a total of 33 variants from eight pharmacogenes. How does the 23andMe product stack up against commercially available PGx tests? Is the 23andMe product any good?

View the blog post now!

 

To stay informed about pharmacogenomics, join our mailing list!